Lv1
40 积分 2026-04-21 加入
Effectiveness of Lebrikizumab Treatment for Patients with Atopic Dermatitis Switched from Dupilumab or Tralokinumab: A 48-Week Real-World Retrospective Study
10天前
已完结
Evolution of dupilumab‐associated conjunctivitis in patients with atopic dermatitis after switching dupilumab to tralokinumab or Janus kinase inhibitors (RESO‐ADOC study)
11天前
已完结
Real-World Chinese Study of the Effectiveness and Safety of Switching From Dupilumab to Stapokibart in Patients With Moderate-to-Severe Atopic Dermatitis
11天前
已完结
Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry
11天前
已完结
Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis
12天前
已完结
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
17天前
已完结
Global, Regional, and National Burden of Atopic Dermatitis: Insights From the Global Burden of Disease Study 2021
1个月前
已完结
Global, Regional, and National Burden of Atopic Dermatitis: Insights From the Global Burden of Disease Study 2021
1个月前
已关闭
Burden of Atopic Dermatitis in China and Its Provinces, 1990–2021: A Global Burden of Disease 2021 Analysis
1个月前
已完结
Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study
1个月前
已完结
皖公网安备34019202002308
